Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:48:24 EDT Sat 09 Aug 2025
Enter Symbol
or Name
USA
CA



Z:NBY - NOVABAY PHARMACEUTICALS INC - https://investors.novabay.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NBY - Z0.10.5907·0.693.10.5925+0.01933.422.711680.60  0.62  0.571.0099  0.361119:36:35May 1515 min RT 2¢

Recent Trades - Last 10 of 68
Time ETExPriceChangeVolume
19:36:35Z0.64010.05841,000
19:36:18Z0.62760.04591,000
19:36:11Z0.64660.06491,000
19:36:04Z0.64490.06321,000
19:35:56Z0.64310.06141,000
19:35:49Z0.64110.05941,000
19:34:38Z0.63770.0561,000
19:34:26Z0.62520.04351,000
19:27:59Z0.6130.03131,000
19:22:15Z0.6010.0193998

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-15 14:19U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2025-04-04 20:36U:NBYSEDAR Audited Annual Financial StatementsSEDAR MD & A
2025-04-04 20:31U:NBYSEDAR Annual Information FormSEDAR Annual Information Form
2025-03-07 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
2025-01-23 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
2024-12-19 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
2024-12-09 06:50U:NBYNews ReleaseNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
2024-11-22 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
2024-11-15 08:00U:NBYNews ReleaseProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand
2024-11-07 17:04U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2024-11-07 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
2024-11-06 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
2024-10-29 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
2024-09-20 08:30U:NBYNews ReleaseAcumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals
2024-09-20 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
2024-08-13 17:52U:NBYSEDAR Interim MD & ASEDAR Interim Financial Statements
2024-08-13 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results